Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface.

[1]  M. Mariani,et al.  Minimally invasive aortic valve replacement. , 1997, The Journal of thoracic and cardiovascular surgery.

[2]  John D Lambris,et al.  Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. , 1996, Journal of immunology.

[3]  L. Matis,et al.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. , 1995, The Journal of clinical investigation.

[4]  B. Nilsson,et al.  Complement activation during cardiopulmonary bypass: effects of immobilized heparin. , 1994, The Annals of thoracic surgery.

[5]  M. Pekna.  Complement activation by polymethyl methacrylate (PMMA) is minimized by end-point heparin attachment , 1993 .

[6]  W. Baumgartner,et al.  Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[7]  B. Nilsson,et al.  Evidence for iC3 generation during cardiopulmonary bypass as the result of blood‐gas interaction , 1993, Clinical and experimental immunology.

[8]  B. Nilsson,et al.  Complement activation by polymethyl methacrylate minimized by end-point heparin attachment. , 1993, Biomaterials.

[9]  P. Ward,et al.  Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. , 1992, Journal of immunology.

[10]  T. Kinoshita,et al.  Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. , 1992, The Journal of biological chemistry.

[11]  B. Nilsson,et al.  Generation of iC3 at the Interface between Blood and Gas , 1992, Scandinavian journal of immunology.

[12]  W. Greeley,et al.  Assessing the effect of cardiopulmonary bypass on the brain. , 1991, The Annals of thoracic surgery.

[13]  P. Sims,et al.  The response of human platelets to activated components of the complement system. , 1991, Immunology today.

[14]  E. Reed,et al.  Neutrophil CR3 expression and specific granule exocytosis are controlled by different signal transduction pathways. , 1991, Journal of immunology.

[15]  M. Oppermann,et al.  Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. , 1991, The Annals of thoracic surgery.

[16]  M. Oppermann,et al.  Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies. , 1991, Complement and inflammation.

[17]  S. Thelin,et al.  Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. , 2008, Artificial organs.

[18]  D. Altieri,et al.  A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). , 1990, The Journal of biological chemistry.

[19]  Johnson Rj.  Complement activation by biomaterials. , 1990 .

[20]  J. Tinker.  Cardiopulmonary Bypass: Current Concepts and Controversies , 1989 .

[21]  E. Fosse,et al.  Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro. , 1989, The Journal of thoracic and cardiovascular surgery.

[22]  S. Wright,et al.  Transient adhesion of neutrophils to endothelium , 1989, The Journal of experimental medicine.

[23]  John D Lambris,et al.  Cell surface proteins reacting with activated complement components. , 1989, Complement and inflammation.

[24]  H. Kozono,et al.  C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. , 1988, Journal of immunology.

[25]  J. Harlan,et al.  Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. , 1988, The Journal of clinical investigation.

[26]  S. Frøland,et al.  Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70. , 1988, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[27]  B. Nilsson,et al.  An Assessment of the Extent of Antigenic Analogy between Physiologically Bound C3 and C3 Denatured by Sodium Dodecyl Sulphate , 1985, Scandinavian journal of immunology.

[28]  S. Frøland,et al.  Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex , 1985, Scandinavian journal of immunology.

[29]  J. Lambris,et al.  Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes , 1982, The Journal of experimental medicine.

[30]  R. Larsson,et al.  Determination of platelet adhesion to polyethylene and heparinized surfaces with the aid of bioluminescence and 51chromium labelled platelets. , 1977, Thrombosis Research.

[31]  H. Müller-Eberhard,et al.  ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM , 1969, The Journal of experimental medicine.